These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26288226)
1. Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. Nijhoff MF; Engelse MA; Dubbeld J; Braat AE; Ringers J; Roelen DL; van Erkel AR; Spijker HS; Bouwsma H; van der Boog PJ; de Fijter JW; Rabelink TJ; de Koning EJ Am J Transplant; 2016 Jan; 16(1):246-53. PubMed ID: 26288226 [TBL] [Abstract][Full Text] [Related]
2. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407 [TBL] [Abstract][Full Text] [Related]
5. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541 [TBL] [Abstract][Full Text] [Related]
6. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445 [TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study. Sutherland AI; Akhtar MZ; Zilvetti M; Brockmann J; Ruse S; Fuggle SV; Sinha S; Harden P; Friend PJ Am J Transplant; 2014 Mar; 14(3):677-84. PubMed ID: 24612687 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial. Bösmüller C; Ollinger R; Sieb M; Weissenbacher A; Schneeberger S; Pratschke J; Margreiter R Ann Transplant; 2012 Dec; 17(4):45-51. PubMed ID: 23274323 [TBL] [Abstract][Full Text] [Related]
9. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis. Sampaio MS; Chopra B; Sureshkumar KK Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563 [TBL] [Abstract][Full Text] [Related]
10. Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. Chan K; Taube D; Roufosse C; Cook T; Brookes P; Goodall D; Galliford J; Cairns T; Dorling A; Duncan N; Hakim N; Palmer A; Papalois V; Warrens AN; Willicombe M; McLean AG Transplantation; 2011 Oct; 92(7):774-80. PubMed ID: 21836540 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction. Tan J; Yang S; Cai J; Guo J; Huang L; Wu Z; Chen J; Liao L Diabetes; 2008 Oct; 57(10):2666-71. PubMed ID: 18633105 [TBL] [Abstract][Full Text] [Related]
12. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal. Saull HE; Enderby CY; Gonwa TA; Wadei HM Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849 [TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin. Reddy KS; Devarapalli Y; Mazur M; Hamawi K; Chakkera H; Moss A; Mekeel K; Post D; Heilman R; Mulligan D Transplant Proc; 2010; 42(6):2006-8. PubMed ID: 20692393 [TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. Kaufman DB; Leventhal JR; Axelrod D; Gallon LG; Parker MA; Stuart FP Am J Transplant; 2005 Oct; 5(10):2539-48. PubMed ID: 16162205 [TBL] [Abstract][Full Text] [Related]
15. Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study. Nordheim E; Birkeland KI; Åsberg A; Hartmann A; Horneland R; Jenssen T Eur J Endocrinol; 2018 Oct; 179(4):251-259. PubMed ID: 30299895 [TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
18. An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. Cherukuri A; Salama AD; Carter C; Smalle N; McCurtin R; Hewitt EW; Hernandez-Fuentes M; Clark B; Baker RJ Am J Transplant; 2012 Apr; 12(4):919-31. PubMed ID: 22390816 [TBL] [Abstract][Full Text] [Related]
19. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004 [TBL] [Abstract][Full Text] [Related]
20. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]